undefined undefined undefined

Oral anticoagulation therapy in atrial fibrillation patients with advanced chronic kidney disease: CODE-AF Registry

Event: ESC Congress 2022

Topic: Oral Anticoagulation

Session: Oral anticoagulation in real life

Access

Like

Label adherence of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation: A nationwide study

Event: ESC Congress 2019

Topic: Oral Anticoagulation

Session: Atrial fibrillation and oral anticoagulation 2

Access

Like

When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation?: A multi-center prospective randomized study

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session: Moderated ePosters 3: atrial fibrillation ablation: dealing with gaps and safety

Access

Like

Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population

Event: ESC Congress 2018

Topic: Stroke Prevention, Other

Session: Atrial fibrillation - Stroke prevention

Access

Like

How long the duration of atrial fibrillation is associated with poor rhythm outcome after catheter ablation?

Event: ESC Congress 2018

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation ablation

Access

Like

Influence of reimbursement of non-vitamin K antagonist oral anticoagulants on overall prescription rates of oral anticoagulation: A nationwide study using the Korean National Health Insurance Data

Event: EHRA 2018

Topic: Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation

Session: Atrial fibrillation - Clinical

Access

Like

Efficacy and safety of unilateral groin puncture with single trans-septal catheter ablation for paroxysmal atrial fibrillation: A multi-center prospective randomized study

Event: EHRA 2018

Topic: Rhythm Control, Catheter Ablation

Session: Atrial fibrillation ablation - Mechanisms and outcomes

Access

Like

Favorable effect of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with liver cirrhosis

Event: ESC Congress 2017

Topic: Antiarrhythmic drugs

Session: Drug treatment in patients with arrhythmia

Access

Like

Poor rhythm outcome of catheter ablation for early onset atrial fibrillation in women: mechanistic insight.

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation ablation

Access

Like

Pulmonary vein isolation vs. additional linear ablation for patients with persistent atrial fibrillation those changed to paroxysmal type with antiarrhythmic therapy: a multi-center randomized study

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Catheter ablation (Atrial Fibrillation)

Session: Atrial Fibrillation - Catheter ablation

Access

Like

undefined undefined undefined

Contributor content

Oral anticoagulation therapy in atrial fibrillation patients with advanced chronic kidney disease: CODE-AF Registry

Label adherence of non-vitamin K antagonist oral anticoagulants and clinical outcomes in patients with atrial fibrillation: A nationwide study

When is it appropriate to stop non-vitamin K antagonist oral anticoagulants before catheter ablation of atrial fibrillation?: A multi-center prospective randomized study

Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population

How long the duration of atrial fibrillation is associated with poor rhythm outcome after catheter ablation?

Influence of reimbursement of non-vitamin K antagonist oral anticoagulants on overall prescription rates of oral anticoagulation: A nationwide study using the Korean National Health Insurance Data

Efficacy and safety of unilateral groin puncture with single trans-septal catheter ablation for paroxysmal atrial fibrillation: A multi-center prospective randomized study

Favorable effect of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with liver cirrhosis

Poor rhythm outcome of catheter ablation for early onset atrial fibrillation in women: mechanistic insight.

Pulmonary vein isolation vs. additional linear ablation for patients with persistent atrial fibrillation those changed to paroxysmal type with antiarrhythmic therapy: a multi-center randomized study

ESC 365 is supported by